Lilly Endowment Inc sold $88M of LLY
owner at ELI LILLY & Co. 99,452 shares at an average of $882.70, traded Feb 21, 2025, filed Feb 24, 2025.
Score components
- +12Role10% owner
- +25Trade size$87.8M at market
- 0Share of holdings soldSold 0.1% of holdings
- +8Cluster2 insiders selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001415889-25-005240, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Feb 21, 2025 | SOpen-market sale Common Stock | -20,542 | $877.31 | $18M | 96,601,320 | Feb 24, 2025 |
| Feb 21, 2025 | SOpen-market sale Common Stock | -9,766 | $878.43 | $8.6M | 96,591,554 | Feb 24, 2025 |
| Feb 21, 2025 | SOpen-market sale Common Stock | -19,490 | $879.71 | $17M | 96,572,064 | Feb 24, 2025 |
| Feb 21, 2025 | SOpen-market sale Common Stock | -5,781 | $880.35 | $5.1M | 96,566,283 | Feb 24, 2025 |
| Feb 21, 2025 | SOpen-market sale Common Stock | -2,908 | $881.57 | $2.6M | 96,563,375 | Feb 24, 2025 |
| Feb 21, 2025 | SOpen-market sale Common Stock | -4,079 | $882.50 | $3.6M | 96,559,296 | Feb 24, 2025 |
| Feb 21, 2025 | SOpen-market sale Common Stock | -3,640 | $883.43 | $3.2M | 96,555,656 | Feb 24, 2025 |
| Feb 21, 2025 | SOpen-market sale Common Stock | -5,182 | $884.45 | $4.6M | 96,550,474 | Feb 24, 2025 |
| Feb 21, 2025 | SOpen-market sale Common Stock | -1,221 | $885.47 | $1.1M | 96,549,253 | Feb 24, 2025 |
| Feb 21, 2025 | SOpen-market sale Common Stock | -1,829 | $886.44 | $1.6M | 96,547,424 | Feb 24, 2025 |
| Feb 21, 2025 | SOpen-market sale Common Stock | -2,700 | $887.45 | $2.4M | 96,544,724 | Feb 24, 2025 |
| Feb 21, 2025 | SOpen-market sale Common Stock | -1,087 | $888.75 | $966k | 96,543,637 | Feb 24, 2025 |
| Feb 21, 2025 | SOpen-market sale Common Stock | -2,700 | $889.99 | $2.4M | 96,540,937 | Feb 24, 2025 |
| Feb 21, 2025 | SOpen-market sale Common Stock | -7,452 | $890.82 | $6.6M | 96,533,485 | Feb 24, 2025 |
| Feb 21, 2025 | SOpen-market sale Common Stock | -6,152 | $891.79 | $5.5M | 96,527,333 | Feb 24, 2025 |
| Feb 21, 2025 | SOpen-market sale Common Stock | -3,357 | $892.78 | $3.0M | 96,523,976 | Feb 24, 2025 |
| Feb 21, 2025 | SOpen-market sale Common Stock | -1,566 | $893.75 | $1.4M | 96,522,410 | Feb 24, 2025 |
Related signals
Other insiders at ELI LILLY & Co and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 29Weak | ELI LILLY & Co | Donald A Zakrowski SVP, Finance, & CAO | $716k 1,000 shares | -17% | |
| 27Weak | ELI LILLY & Co | Ilya Yuffa EVP & President, LLY Int'l | $937k 1,250 shares | -4% | |
| 30Weak | ELI LILLY & Co | Donald A Zakrowski SVP, Finance, & CAO | $818k 1,000 shares | -15% | |
| 45Moderate | ELI LILLY & Co | Lilly Endowment Inc owner | $204M 220,000 shares | -0% | |
| 37Weak | LLYsell ELI LILLY & Co | Lilly Endowment Inc owner | $203M 225,000 shares | -0% | |
| 45Moderate | ELI LILLY & Co | Lilly Endowment Inc owner | $1.6B 60,432 shares | -0% | |
| 45Moderate | ELI LILLY & Co | Lilly Endowment Inc owner | $13M 14,685 shares | -0% | |
| 45Moderate | ELI LILLY & Co | Lilly Endowment Inc owner | $8.8M 9,985 shares | -0% | |
| 45Moderate | ELI LILLY & Co | Lilly Endowment Inc owner | $31M 35,446 shares | -0% | |
| 28Weak | ELI LILLY & Co | Daniel Skovronsky EVP, CSO & Pres. LRL & LLY Imm | $4.3M 5,000 shares | -4% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.